Mittehemolüütlus

Mittehemolüütlus, also known as non-hemolytic anemia, is a type of anemia characterized by a reduced number of red blood cells (RBCs) in the blood, but without significant hemolysis, which is the destruction of RBCs. This condition can be caused by various factors, including nutritional deficiencies, chronic diseases, or genetic disorders. Unlike hemolytic anemias, where RBCs are destroyed at an increased rate, non-hemolytic anemias result from decreased RBC production or increased RBC destruction at a normal rate.

The diagnosis of non-hemolytic anemia typically involves a complete blood count (CBC) and a reticulocyte count. A reticulocyte is a young RBC that contains RNA and is visible under a microscope. An increased reticulocyte count indicates increased RBC production, which is a common finding in non-hemolytic anemias. Other diagnostic tests may include blood tests to assess iron levels, vitamin B12, and folate, as well as bone marrow examination to evaluate RBC production.

Treatment for non-hemolytic anemia depends on the underlying cause. Nutritional deficiencies, such as iron or vitamin B12 deficiency, can be treated with oral supplements or injections. Chronic diseases, such as chronic kidney disease or inflammatory bowel disease, may require specific treatments to manage the underlying condition. Genetic disorders may have no specific treatment, but supportive care can be provided. In some cases, blood transfusions may be necessary to alleviate symptoms of severe anemia. Regular follow-up with a healthcare provider is essential to monitor the condition and adjust treatment as needed.